|
Qlik sees data analytics continues to evolve and digitisation to spur efficiency in pharma & healthcare sectors
|
|
Nandita Vijay, Bengaluru
September 18 , 2017
|
|
|
Qlik, a global business intelligence provider, has sighted opportunities
in the pharmaceutical and healthcare sector in India. This is primarily
because the company has seen that India has the ability to leapfrog
other mature markets going by the data literacy that helps to accelerate
the growth.
Data analytics continues to evolve and this allows
both pharma and healthcare to stall an unforeseen crisis. Its predictive
approach can identify potential critical situations at pharma
production plants. For healthcare providers, during medical emergencies
data analytics is seen to dramatically improve the overall healthcare
outcomes.
In the international arena, Qlik is much accepted. For
instance at the University Hospital in Gothenburg, the largest in
northern Europe, doctors were able to gain a holistic overview of the
overall patient condition. The differentiated approach significantly
improved the number of favourable medical outcomes and reduce
complications in treatment, but also reduced the hospital’s annual
expenditure by around €750,000. At an Australian hospital too, Qlik was
deployed to identify data from disparate parameters such as incident,
hospital activity, and ward roster to identify the falls that typically
occurred in and around the geriatric wards. This insight helped the
hospital to reduce fall incidents by 40% and the cost of care in these
wards by 5%, and increase patient satisfaction.
“These examples
serve to highlight the prominent role that data analytics can play in
adding value to stakeholders in the pharmaceutical and healthcare supply
chains. In India, Lupin and Wockhardt have deployed Qlik. The two
companies are able to monitor critical events in real-time, and
accurately identify inefficiencies to take corrective actions as swiftly
as possible.
“Our data analytics can be easily accessed by any
business user. With the rapid digitisation that has taken place in India
in the last couple of years, the country is showing a readiness to
adopt data analytics to drive its growth and strengthen its position as
an emerging technological powerhouse”, Souma Das, Managing Director,
Qlik India told Pharmabiz in an email.
Customers using Qlik
Sense, QlikView and Qlik Cloud, have an understanding to explore data
that enable them to make better data-driven decisions. The acceptance of
Qlik is a proof that the Indian market is ready to make the analytical
leap and reap the benefits that a data-led approach can bring, he added.
Sharing
the Wockhardt experience with Qlik, Das said that the company required a
data analytics solution which was transparent, easy to use, agile and
scalable to enable better decision-making. Qlik, with its successful
track record in delivering the best outcomes, was naturally the
preferred choice for Wockhardt hospitals in the country.
Huge
volumes of data was extracted from disparate sources, to generate
strategic insights. Revenue evaluation and better MIS (management
information system) for financial data also allowed effective cost
optimisation measures. Pricing analysis and cost audits aided the
organisation to significantly decrease its operational expenditure, said
Das.
Lupin Pharmaceuticals deployed Qlik to analyse data across
its supply chain, finance, and research and development departments,
with a view of optimising its operations and driving rapid, fact-based
decision-making. “The Qlik-powered Lupin Enhanced Analytical Portal
(LEAP) helped the company to integrate and analyse massive volumes of
data from various internal and external data sources and information
systems, while minimising the total cost-of-ownership,” he said.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|